Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)

Detalles Bibliográficos
Autores principales: Hasmann, Sandra, Paal, Michael, Füeßl, Louise, Fischereder, Michael, Schönermarck, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545767/
https://www.ncbi.nlm.nih.gov/pubmed/34723234
http://dx.doi.org/10.1016/j.lanepe.2021.100237
_version_ 1784590063856779264
author Hasmann, Sandra
Paal, Michael
Füeßl, Louise
Fischereder, Michael
Schönermarck, Ulf
author_facet Hasmann, Sandra
Paal, Michael
Füeßl, Louise
Fischereder, Michael
Schönermarck, Ulf
author_sort Hasmann, Sandra
collection PubMed
description
format Online
Article
Text
id pubmed-8545767
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85457672021-10-26 Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.) Hasmann, Sandra Paal, Michael Füeßl, Louise Fischereder, Michael Schönermarck, Ulf Lancet Reg Health Eur Letter Elsevier 2021-10-25 /pmc/articles/PMC8545767/ /pubmed/34723234 http://dx.doi.org/10.1016/j.lanepe.2021.100237 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Letter
Hasmann, Sandra
Paal, Michael
Füeßl, Louise
Fischereder, Michael
Schönermarck, Ulf
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
title Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
title_full Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
title_fullStr Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
title_full_unstemmed Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
title_short Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
title_sort humoral immunity to sars-cov-2 vaccination in haemodialysis patients: (response to: humoral and cellular immunity to sars-cov-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mrna-1273 or bnt162b2 mrna vaccine.)
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545767/
https://www.ncbi.nlm.nih.gov/pubmed/34723234
http://dx.doi.org/10.1016/j.lanepe.2021.100237
work_keys_str_mv AT hasmannsandra humoralimmunitytosarscov2vaccinationinhaemodialysispatientsresponsetohumoralandcellularimmunitytosarscov2vaccinationinrenaltransplantversusdialysispatientsaprospectivemulticenterobservationalstudyusingmrna1273orbnt162b2mrnavaccine
AT paalmichael humoralimmunitytosarscov2vaccinationinhaemodialysispatientsresponsetohumoralandcellularimmunitytosarscov2vaccinationinrenaltransplantversusdialysispatientsaprospectivemulticenterobservationalstudyusingmrna1273orbnt162b2mrnavaccine
AT fueßllouise humoralimmunitytosarscov2vaccinationinhaemodialysispatientsresponsetohumoralandcellularimmunitytosarscov2vaccinationinrenaltransplantversusdialysispatientsaprospectivemulticenterobservationalstudyusingmrna1273orbnt162b2mrnavaccine
AT fischeredermichael humoralimmunitytosarscov2vaccinationinhaemodialysispatientsresponsetohumoralandcellularimmunitytosarscov2vaccinationinrenaltransplantversusdialysispatientsaprospectivemulticenterobservationalstudyusingmrna1273orbnt162b2mrnavaccine
AT schonermarckulf humoralimmunitytosarscov2vaccinationinhaemodialysispatientsresponsetohumoralandcellularimmunitytosarscov2vaccinationinrenaltransplantversusdialysispatientsaprospectivemulticenterobservationalstudyusingmrna1273orbnt162b2mrnavaccine

Ejemplares similares